BioCentury | Dec 20, 2019
Product Development

Rise of the first-time biotech CEO

...the challenges of being of a CEO”, said Sandy Zweifach, co-founder and former CEO of Nuvelution Pharma Inc....
...changing roles, you go back to that,” she said. Karen Tkach Tuzman, Associate Editor Atlas Venture Venrock Agios Pharmaceuticals Inc. Nuvelution Pharma Inc. GammaDelta...
BioCentury | Dec 14, 2019
Company News

Management Tracks: Alector hires new president, COO and appoints R&D committee co-chairs; plus Pyxis, Translate Bio, Canaan, PMV, Janpix, Kiadis and more

...NASDAQ:AFMD). Janpix Inc. appointed Sanford Zweifach as executive chairman. Zweifach was co-founder and CEO of Nuvelution Pharma Inc....
...Inc. (NASDAQ:GHDX) and Jaegar was the regional sales director for metabolics at AbbVie Inc. (NYSE:ABBV). Nuvelution Pharma Inc....
...director at Exagen Inc. (NASDAQ:XGN). BioCentury Staff Alector Inc. Translate Bio Inc. Janpix Inc. PMV Pharmaceuticals Inc. Canaan Kiadis Pharma N.V. Clarus Therapeutics Inc. Nuvelution Pharma Inc....
BioCentury | Apr 8, 2019
Company News

Management tracks: WuXi AppTec, Kymab, Acceleron

...Pa.) appointed Sanford Zweifach as the company’s first chairman. Zweifach is co-founder and CEO of Nuvelution Pharma Inc....
BioCentury | Oct 26, 2018
Company News

Management tracks: Principia, Orexo, Polyphor, MeiraGTx

...interim CEO until a permanent replacement is found. She will also join the company’s board. Nuvelution Pharma Inc....
BioCentury | Jul 21, 2017
Finance

Clarus shares

...is a founding investor in three risk-sharing companies: SFJ Pharmaceuticals Inc. , Avillion LLP and Nuvelution Pharma Inc....
...Avillion, last year closed a $105 million fund dedicated to risk-sharing investments. Virginia Li, Staff Writer Avillion LLP Nuvelution Pharma Inc. SFJ...
BioCentury | Jul 20, 2015
Financial News

Nuvelution Pharma Inc. financial update

...Nuvelution Pharma Inc. , South San Francisco, Calif. Business: Finance Date announced: 2015-07-13 Note: Nuvelution Pharma Inc. debuted...
BioCentury | Jul 20, 2015
Finance

Risk-seeking behavior

...Clarus Ventures' third disclosed risk-sharing start-up looks to be its broadest so far, as Nuvelution Pharma Inc. expects...
BioCentury | Jul 14, 2015
Financial News

Nuvelution debuts with funding from Clarus, Novo A/S

Nuvelution Pharma Inc. (San Francisco, Calif.) debuted on Monday with an undisclosed investment from Clarus Ventures and Novo A/S (Hellerup, Denmark). Nuvelution plans to form risk-sharing partnership with biotech and pharma companies in which Nuvelution...
Items per page:
1 - 8 of 8
BioCentury | Dec 20, 2019
Product Development

Rise of the first-time biotech CEO

...the challenges of being of a CEO”, said Sandy Zweifach, co-founder and former CEO of Nuvelution Pharma Inc....
...changing roles, you go back to that,” she said. Karen Tkach Tuzman, Associate Editor Atlas Venture Venrock Agios Pharmaceuticals Inc. Nuvelution Pharma Inc. GammaDelta...
BioCentury | Dec 14, 2019
Company News

Management Tracks: Alector hires new president, COO and appoints R&D committee co-chairs; plus Pyxis, Translate Bio, Canaan, PMV, Janpix, Kiadis and more

...NASDAQ:AFMD). Janpix Inc. appointed Sanford Zweifach as executive chairman. Zweifach was co-founder and CEO of Nuvelution Pharma Inc....
...Inc. (NASDAQ:GHDX) and Jaegar was the regional sales director for metabolics at AbbVie Inc. (NYSE:ABBV). Nuvelution Pharma Inc....
...director at Exagen Inc. (NASDAQ:XGN). BioCentury Staff Alector Inc. Translate Bio Inc. Janpix Inc. PMV Pharmaceuticals Inc. Canaan Kiadis Pharma N.V. Clarus Therapeutics Inc. Nuvelution Pharma Inc....
BioCentury | Apr 8, 2019
Company News

Management tracks: WuXi AppTec, Kymab, Acceleron

...Pa.) appointed Sanford Zweifach as the company’s first chairman. Zweifach is co-founder and CEO of Nuvelution Pharma Inc....
BioCentury | Oct 26, 2018
Company News

Management tracks: Principia, Orexo, Polyphor, MeiraGTx

...interim CEO until a permanent replacement is found. She will also join the company’s board. Nuvelution Pharma Inc....
BioCentury | Jul 21, 2017
Finance

Clarus shares

...is a founding investor in three risk-sharing companies: SFJ Pharmaceuticals Inc. , Avillion LLP and Nuvelution Pharma Inc....
...Avillion, last year closed a $105 million fund dedicated to risk-sharing investments. Virginia Li, Staff Writer Avillion LLP Nuvelution Pharma Inc. SFJ...
BioCentury | Jul 20, 2015
Financial News

Nuvelution Pharma Inc. financial update

...Nuvelution Pharma Inc. , South San Francisco, Calif. Business: Finance Date announced: 2015-07-13 Note: Nuvelution Pharma Inc. debuted...
BioCentury | Jul 20, 2015
Finance

Risk-seeking behavior

...Clarus Ventures' third disclosed risk-sharing start-up looks to be its broadest so far, as Nuvelution Pharma Inc. expects...
BioCentury | Jul 14, 2015
Financial News

Nuvelution debuts with funding from Clarus, Novo A/S

Nuvelution Pharma Inc. (San Francisco, Calif.) debuted on Monday with an undisclosed investment from Clarus Ventures and Novo A/S (Hellerup, Denmark). Nuvelution plans to form risk-sharing partnership with biotech and pharma companies in which Nuvelution...
Items per page:
1 - 8 of 8